Craig-Hallum analyst Greg Palm raised the firm’s price target on BlueLinx to $135 from $125 and keeps a Buy rating on the shares. The firm notes BlueLinx reported mixed Q2 results as overall weakness in end market demand was offset by strong margins and overall execution. Craig-Hallum is hopeful that declining rates can help jumpstart the recovery although it is not expecting much change this year and expects any rebound will likely begin in 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BXC:
